GeneDx Holdings Corp. (WGS): Cost of Revenue
$129.37M
Year ended 2025-12-31
$139.18M
Trailing 12 months to 2026-06-30
-20.9%
3-year compound annual growth
-5.9%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $129.37M | +16.5% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | $111.05M | -1.3% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | $112.56M | -56.9% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | $261.44M | +14.3% | 2024-02-23, From 2022-01-01 |
| 2021-12-31 | $228.80M | +30.5% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $175.30M | +54.6% | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | $113.39M | n/a | 2022-03-14, From 2019-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $129.37M | +16.5% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $89.27M | +33.4% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $156.01M | +33.1% |
| Vsee Health, Inc. (VSEE) | 2025-12-31 | $7.26M | +123.9% |
| EUDA Health Holdings Ltd (EUDA) | 2025-12-31 | $3.83M | +17.8% |
| Longduoduo Co Ltd (LDDD) | 2025-06-30 | $91.1K | -47.4% |
| Agape ATP Corp (ATPC) | 2025-12-31 | $686.0K | +21.7% |
Compare WGS, OMDA, SRTA, VSEE side by side · Screen every company in Services-Health Services ↗